PPMS Market Analysis, Emerging Therapies, and Growth Forecast - 2032

Introduction Primary Progressive Multiple Sclerosis (PPMS) is a distinct form of multiple sclerosis characterized by a gradual and continuous worsening of neurological function without distinct relapses or remissions. Affecting approximately 10-15% of all individuals diagnosed with multiple sclerosis, PPMS poses unique challenges for patients and healthcare providers alike. This article presents a comprehensive analysis of the PPMS market, highlighting emerging therapies and providing a growth forecast leading up to 2032. Understanding Primary Progressive Multiple Sclerosis What is PPMS? PPMS is a chronic neurological condition that primarily impacts adults, manifesting symptoms such as: Muscle weakness Coordination and balance issues Cognitive impairment Fatigue Unlike other forms of MS, PPMS does not feature flare-ups, making its management particularly challenging. The disease progresses continuously, leading to an accumulation of disability over time. Epidemiology of PPMS The...